| Literature DB >> 34235105 |
Ruofan Sheng1,2, Jing Huang3, Weiguo Zhang4, Kaipu Jin1,2, Li Yang1,2, Huanhuan Chong1,2, Jia Fan5,6, Jian Zhou5,6, Dijia Wu3, Mengsu Zeng1,2,6.
Abstract
PURPOSE: Liver imaging reporting and data system (LI-RADS) classification, especially the identification of LR-3 to 5 lesions with hepatocellular carcinoma (HCC) probability, is of great significance to treatment strategy determination. We aimed to develop a semi-automatic LI-RADS grading system on multiphase gadoxetic acid-enhanced MRI using deep convolutional neural networks (CNN). PATIENTS AND METHODS: An internal data set of 439 patients and external data set of 71 patients with suspected HCC were included and underwent gadoxetic acid-enhanced MRI. The expert-guided LI-RADS grading system consisted of four deep 3D CNN models including a tumor segmentation model for automatic diameter estimation and three classification models of LI-RADS major features including arterial phase hyper-enhancement (APHE), washout and enhancing capsule. An end-to-end learning system comprising single deep CNN model that directly classified the LI-RADS grade was developed for comparison.Entities:
Keywords: HCC; LI-RADS; MRI; deep learning; hepatocellular carcinoma; liver imaging reporting and data system; magnetic resonance imaging
Year: 2021 PMID: 34235105 PMCID: PMC8255313 DOI: 10.2147/JHC.S316385
Source DB: PubMed Journal: J Hepatocell Carcinoma ISSN: 2253-5969
Figure 1The proposed expert-guided LI-RADS grading system consisted of three modules: the data preprocessing module that cropped, resized and normalized the ROI centering around the target tumor; the CNN modules comprising the tumor segmentation model and three major imaging feature classification models; and the post-processing module which calculated the maximum tumor diameter from the segmentation mask and obtained the LI-RADS grade according to the diameter and inferred presence of the major features.
Figure 2The convolutional neural network architecture of liver tumor segmentation model, which combines U-Net with bottleneck layer (BL).
Figure 3The convolutional neural network architectures of classification models: (A) the models for arterial phase hyper-enhancement and washout, (B) the model for capsule feature.
The Distribution of Tumor Diameters, Presence of Major Features and Assigned LI-RADS Categories for Both Internal and External Data Set
| Fold-1 | 13 | 75 | 26 | 62 | 43 | 45 | 10 | 46 | 32 | 17 | 18 | 53 |
| Fold-2 | 10 | 77 | 31 | 56 | 35 | 52 | 9 | 44 | 34 | 18 | 17 | 52 |
| Fold-3 | 11 | 77 | 24 | 64 | 35 | 53 | 16 | 30 | 42 | 13 | 23 | 52 |
| Fold-4 | 14 | 74 | 35 | 53 | 41 | 47 | 16 | 40 | 32 | 22 | 21 | 45 |
| Fold-5 | 19 | 69 | 34 | 54 | 44 | 44 | 11 | 43 | 34 | 23 | 19 | 46 |
| Total | 67 | 372 | 150 | 289 | 198 | 241 | 62 | 203 | 174 | 93 | 98 | 248 |
| Total | 5 | 66 | 32 | 39 | 27 | 44 | 1 | 14 | 56 | 10 | 12 | 49 |
Abbreviation: APHE, arterial phase hyper-enhancement.
Figure 4The ROC curves of three major imaging feature classification models on (A) internal data set and (B) external data set. The blue, red and green lines represented arterial phase hyper-enhancement (APHE), washout and capsule, respectively. The solid lines stand for the training data set and the dashed lines stand for the testing data set.
The Sensitivity and Specificity of Three Feature Classification Models on Internal Data Set
| APHE | Washout | Capsule | ||
|---|---|---|---|---|
| Sensitivity (95% CI) | 99.9% (94.9%, 100.0%) | 98.5% (92.9%, 100.0%) | 97.8% (91.7%, 100.0%) | |
| Specificity (95% CI) | 100.0% (88.4%, 100.0%) | 98.5% (90.7%, 100.0%) | 97.2% (90.5%, 100.0%) | |
| Sensitivity (95% CI) | 94.6% (85.0%, 100.0%) | 84.8% (74.5%, 100.0%) | 68.9% (58.8%, 80.2%) | |
| Specificity (95% CI) | 79.1% (59.3%, 100.0%) | 64.7% (52.4%, 78.9%) | 61.1% (50.7%, 73.0%) | |
Abbreviation: APHE, arterial phase hyper-enhancement.
The Sensitivity and Specificity of Three Feature Classification Models on External Data Set
| APHE | Washout | Capsule | ||
|---|---|---|---|---|
| Sensitivity (95% CI) | 74.6% (65.5%, 84.5%) | 59.0% (48.7%, 70.8%) | 75.9% (64.8%, 88.3%) | |
| Specificity (95% CI) | 80.0% (48.9%, 100.0%) | 62.5% (50.9%, 76.0%) | 50.3% (39.1%, 63.9%) | |
Abbreviation: APHE, arterial phase hyper-enhancement.
The Dice Coefficient of Three Segmentation Models on All Phase Images of the Internal Data Set
| Mean | 0.85 | 0.87 | 0.82 |
| Pre | 0.86 | 0.87 | 0.83 |
| AP | 0.85 | 0.87 | 0.81 |
| PVP | 0.84 | 0.85 | 0.81 |
| TP | 0.85 | 0.87 | 0.83 |
| Mean | 0.83 | 0.81 | 0.79 |
| Pre | 0.84 | 0.82 | 0.81 |
| AP | 0.82 | 0.80 | 0.78 |
| PVP | 0.82 | 0.78 | 0.77 |
| TP | 0.84 | 0.82 | 0.78 |
Abbreviations: AP, arterial phase; PVP, portal venous phase; TP, transitional phase.